Bevacirel 100 mg Injection
  1. Home
  2. Pharma Products
  3. Reliance Life Sciences Pvt Ltd
  4. Bevacirel 100 mg Injection

Bevacirel 100 mg Injection

Bevacirel 100 mg Injection contains bevacizumab, a targeted monoclonal antibody used in the treatment of several types of cancer. It works by blocking VEGF, a protein that helps tumors form new blood vessels for growth. The medicine is administered by intravenous infusion under the supervision of a qualified healthcare professional.

BUY NOW

Category

Bevacirel 100 mg Injection contains 100 mg of bevacizumab and is used as part of specific anticancer treatment regimens. Bevacizumab inhibits VEGF activity, which can reduce the formation of new blood vessels that support tumor growth. The injection is given as a diluted intravenous infusion according to the prescribed treatment protocol. The dose and treatment schedule depend on the cancer type, combination therapy, and individual patient factors.

Technical Specification

Specification Details
Active Ingredient Bevacizumab 100 mg
Concentration 25 mg/mL
Vial Volume 4 mL
Dosage Form Concentrate for Solution for Infusion
Therapeutic Class Anti-VEGF Monoclonal Antibody
Route of Administration Intravenous Infusion

Product Also Known As

Bevacirel 100 mg Injection, Bevacirel 100 mg/4 mL Injection, Bevacirel Bevacizumab 100 mg Injection, Bevacizumab 100 mg Injection, Bevacizumab 100 mg Infusion, Bevacizumab Oncology Injection